Related references
Note: Only part of the references are listed.Lineage-Restricted Regulation of SCD and Fatty Acid Saturation by MITF Controls Melanoma Phenotypic Plasticity
Yurena Vivas-Garcia et al.
MOLECULAR CELL (2020)
Pyruvate dehydrogenase kinase 1 interferes with glucose metabolism reprogramming and mitochondrial quality control to aggravate stress damage in cancer
Xinyue Deng et al.
JOURNAL OF CANCER (2020)
Cancer cells change their glucose metabolism to overcome increased ROS: One step from cancer cell to cancer stem cell?
Zahra Ghanbari Movahed et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Protein Hydroxylation by Hypoxia-Inducible Factor (HIF) Hydroxylases: Unique or Ubiquitous?
Moritz J. Strowitzki et al.
CELLS (2019)
MITF controls the TCA cycle to modulate the melanoma hypoxia response
Pakavarin Louphrasitthiphol et al.
PIGMENT CELL & MELANOMA RESEARCH (2019)
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1
Michael Hulse et al.
PLOS PATHOGENS (2018)
Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanoma
Paola Falletta et al.
GENES & DEVELOPMENT (2017)
Glucose Deprivation Induces ATF4-Mediated Apoptosis through TRAIL Death Receptors
Raffaella Iurlaro et al.
MOLECULAR AND CELLULAR BIOLOGY (2017)
ROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway
Yang Zhao et al.
MOLECULAR CANCER (2017)
Acriflavine Inhibits Acquired Drug Resistance by Blocking the Epithelial-to-Mesenchymal Transition and the Unfolded Protein Response
Jeroen Dekervel et al.
TRANSLATIONAL ONCOLOGY (2017)
Surviving Stress: Modulation of ATF4-Mediated Stress Responses in Normal and Malignant Cells
Inge M. N. Wortel et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2017)
Increased reactive oxygen species levels cause ER stress and cytotoxicity in andrographolide treated colon cancer cells
Aditi Banerjee et al.
ONCOTARGET (2017)
Glucose availability controls ATF4-mediated MITF suppression to drive melanoma cell growth
Jennifer Ferguson et al.
ONCOTARGET (2017)
Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer
Caroline Wigerup et al.
PHARMACOLOGY & THERAPEUTICS (2016)
PTEN dephosphorylates AKT to prevent the expression of GLUT1 on plasmamembrane and to limit glucose consumption in cancer cells
Suratchanee Phadngam et al.
ONCOTARGET (2016)
Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy?
Nissim Hay
NATURE REVIEWS CANCER (2016)
MITF drives endolysosomal biogenesis and potentiates Wnt signaling in melanoma cells
Diego Ploper et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Inhibition of Aerobic Glycolysis Represses Akt/mTOR/HIF-1α Axis and Restores Tamoxifen Sensitivity in Antiestrogen-Resistant Breast Cancer Cells
Yu Mi Woo et al.
PLOS ONE (2015)
Endoplasmic Reticulum (ER) Stress and Hypoxia Response Pathways Interact to Potentiate Hypoxia-inducible Factor 1 (HIF-1) Transcriptional Activity on Targets Like Vascular Endothelial Growth Factor (VEGF)
Ethel R. Pereira et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Melanocytes as Instigators and Victims of Oxidative Stress
Laurence Denat et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
Oncogenic BRAF Regulates Oxidative Metabolism via PGC1α and MITF
Rizwan Haq et al.
CANCER CELL (2013)
Oxygen-independent Regulation of HIF-1: Novel Involvement of PI3K/AKT/mTOR Pathway in Cancer
Faton Agani et al.
CURRENT CANCER DRUG TARGETS (2013)
Targeting the ATF4 pathway in cancer therapy
Dean C. Singleton et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
Bortezomib represses HIF-1α protein expression and nuclear accumulation by inhibiting both PI3K/Akt/TOR and MAPK pathways in prostate cancer cells
Christina D. Befani et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2012)
Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
Gregg L. Semenza
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
Glucose deprivation activates AMPK and induces cell death through modulation of Akt in ovarian cancer cells
Anna Priebe et al.
GYNECOLOGIC ONCOLOGY (2011)
Hypoxia-induced transcriptional repression of the melanoma-associated oncogene MITF
Erez Feige et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The Coffin-Lowry Syndrome-Associated Protein rsk2 and Neurosecretion
M. Zeniou-Meyer et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2010)
Constitutive HIF-1 activity in malignant melanoma
Silke Kuphal et al.
EUROPEAN JOURNAL OF CANCER (2010)
Hypoxia-Inducible Factors and the Response to Hypoxic Stress
Amar J. Majmundar et al.
MOLECULAR CELL (2010)
Generation of hydrogen peroxide in the melanin biosynthesis pathway
Jose Luis Munoz-Munoz et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2009)
Expression and function of hypoxia inducible factor-1 alpha in human melanoma under non-hypoxic conditions
Caroline N. Mills et al.
MOLECULAR CANCER (2009)
Hypoxia, melanocytes and melanoma - survival and tumor development in the permissive microenvironment of the skin
Barbara Bedogni et al.
PIGMENT CELL & MELANOMA RESEARCH (2009)
Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization
KangAe Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Reactive oxygen species stabilize hypoxia-inducible factor-1 alpha protein and stimulate transcriptional activity via AMP-activated protein kinase in DU145 human prostate cancer cells
Seung-Nam Jung et al.
CARCINOGENESIS (2008)
HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption
I Papandreou et al.
CELL METABOLISM (2006)
HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia
JW Kim et al.
CELL METABOLISM (2006)
Hypoxia-inducible factor 1α is a new target of microphthalmia-associated transcription factor (MITF) in melanoma cells
R Buscà et al.
JOURNAL OF CELL BIOLOGY (2005)
The oxidative stressor arsenite activates vascular endothelial growth factor mRNA transcription by an ATF4-dependent mechanism
CN Roybal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Akt stimulates aerobic glycolysis in cancer cells
RL Elstrom et al.
CANCER RESEARCH (2004)
A phosphoserine-regulated docking site in the protein kinase RSK2 that recruits and activates PDK1
M Frödin et al.
EMBO JOURNAL (2000)
Share Paper
